Application of HMGCoA reductase inhibitor in preparation of medicine used for treating xerophthalmia

Application of HMGCoA reductase inhibitor in preparation of medicine used for treating xerophthalmia

  • CN 103,007,284 A
  • Filed: 01/16/2013
  • Published: 04/03/2013
  • Est. Priority Date: 01/16/2013
  • Status: Active Application
First Claim
Patent Images

1. HMGCoA the purposes of reductase inhibitor in preparation treatment or kind of prevention dry eyes medicine.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×